Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
Dupixent has gained positive opinions from KOLs due to the positive data presented from the asset’s two Phase III clinical ...
Georgia governor says at least 11 people are dead in his state after Hurricane Helene
Gov. Brian Kemp said at least 11 people in his state were killed and dozens are still trapped in homes damaged by Helene. At ...
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
On Friday, the FDA approved Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) ...
Do not feed this to your pets: Dog, cat food recalled after illnesses
The U.S. Food and Drug Administration warns customers to not feed their pets certain lots of these pet food brands as they ...
PressConnects.com (Binghamton) on MSN28m
You can still get free COVID tests. How to sign up and when they'll arrive
The window for obtaining the free tests is now open, and residents can sign up at covidtests.gov. How to order free COVID ...
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of in-clinic ...
AbbVie Seeks Accelerated FDA OK of Teliso-V in Non-Small Cell Lung Cancer
AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...
Free Covid-19 tests are available again. Here’s how to get them
People in the United States can order more free Covid-19 tests from the federal government this fall as the country heads ...
First novel Schizophrenia treatment in decades gains FDA approval
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'
Sanofi recorded 10.72 billion euros ($11.94 billion) in sales for Dupixent in 2023, which includes Regeneron's share.
PharmiWeb44m
Diabetic Gastroparesis Treatment Market: Rising Demand Sparks Innovation and Research
The global diabetic gastroparesis treatment market is poised for significant growth, driven by the increasing prevalence of ...
The Lens47m
Pregnant and hemorrhaging, without a key solution within reach
Lawmakers passed a law designed to limit reproductive rights in Louisiana. But it may also limit patients’ chances of ...